Concepedia

G G Chabot

GG

Statistics

Publications

18

Citations

1.5K

H-Index

17

Active since

1988

Affiliations

Institut Gustave Roussy(Current)

Centre National de la Recherche Scientifique

Inserm

Smiths Detection (France)

Wayne State University

G G Chabot is an author at Institut Gustave Roussy specializing in pharmacology, medicine, and oncology.

Publications per year

1988–1996

18

Publications

18

Phase I and pharmacologic studies of the camptothecin analog irinotecan administered every 3 weeks in cancer patients.

D Abigerges, G G Chabot, Jean‐Pierre Armand et al. · Journal of Clinical Oncology · 1995 · 299 citations

, , +17

Irinotecan (CPT-11) High-Dose Escalation Using Intensive High-Dose Loperamide to Control Diarrhea

D Abigerges, P. Armand, G G Chabot et al. · JNCI Journal of the National Cancer Institute · 1994 · 245 citations

, , +15

Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials

G G Chabot, D Abigerges, G. Catimel et al. · Annals of Oncology · 1995 · 173 citations

, , +11

Phase I and pharmacokinetic study of the camptothecin derivative irinotecan, administered on a weekly schedule in cancer patients.

M Forni, R. Bugat, G G Chabot et al. · PubMed · 1994 · 151 citations

, , +17

Phase I and pharmacokinetic study of irinotecan (CPT-11) administered daily for three consecutive days every three weeks in patients with advanced solid tumors

G. Catimel, G G Chabot, Jean‐Paul Guastalla et al. · Annals of Oncology · 1995 · 109 citations · Full text

, , +16

1–5 of 18